News
Cellzome - kinase inhibitors for therapy
www.gesundheitsindustrie-bw.de
purification (TAP) technology discovered by Bertrand Séraphin and Dr. Guillaume Rigaut at the. EMBL. TAP enables the isolation of protein complexes and the identification of pathways. The two researchers were awarded “European Inventors of the Year 2008” by the. European Commission and the ...
Cellzome - Kinaseinhibitoren in der Therapie
www.gesundheitsindustrie-bw.de
Das Unternehmen erwarb die exklusive Lizenz für die von Dr. Bertrand Séraphin und Dr. Guillaume Rigaut am EMBL erfundene Technologie der „Tandem Affinity ...
European Inventor of the Year 2008
www.finanznachrichten.de
Bertrand Séraphin and Guillaume Rigaut (France) for EMBL: for creating an advanced biotechnological method for purifying biomolecule ...
EPO - The Protein Pros
www.epo.org
As part of their research in the late 1990s, the scientists Bertrand Séraphin and Guillaume Rigaut developed a new way of purifying protein complexes that substantially simplified what had previously been a tedious procedure. Their method - Tandem Affinity Purification (TAP) - is used to discover and ...
sortiert nach Relevanz / Datum